Substanzen · Phenethylamin-Derivate
IPPH (Isopropylphenidate)
- Bevorzugter Name
- IPPH (Isopropylphenidate)
- IUPAC-Name
- propan-2-yl 2-phenyl-2-piperidin-2-ylacetate
- CAS-Nummer der Stammverbindung (Referenz)
- 93148-46-0
- Summenformel
- C16H23NO2
- Molekulargewicht
- 261.36 g/mol
- InChIKey
- AZVPADMEIMLODT-UHFFFAOYSA-N
- PubChem
- CID 68314762
- Quelle
- PubChem
- Geprüfte Synonyme und Katalogkürzel
-
Isopropylphenidate IPPH IPH IPPD
Passende Artikel im aktuellen Shop-Katalog
Geprüftes Pharmakologie- & Toxikologie-Dossier
IPPH (Isopropylphenidate)
Rezeptor-Telemetrie & Wirkmechanismus
IPPH is the isopropyl ester analogue of methylphenidate and a dopamine/norepinephrine reuptake inhibitor. The bulkier ester is associated, in anecdotal comparison and in the lower intensity of the PsychonautWiki common band relative to its milligram size, with a smoother, less jittery stimulant than 4F-MPH or racemic methylphenidate. It does not release serotonin and it is not an entactogen. The reference IUPAC is the non-stereospecific name propan-2-yl 2-phenyl-2-piperidin-2-ylacetate.
Biotransformation & Active Metabolites
Ester hydrolysis yields the corresponding phenylpiperidineacetic acid, analogous to ritalinic acid, which is not the active stimulant. IPPH is not a prodrug of 4F-MPH. CAS 93148-46-0 is this isopropyl ester, not methylphenidate and not 4F-MPH (CAS 1354631-33-6).
Zeitliche Pharmakokinetik
Milder functional stimulant. Wakefulness and focus with less peripheral jitter than 4F-MPH, still a real NDRI with a crash and insomnia if pushed.
- Onset 10–30 minutes
- Peak Window 1.5–2.5 hours
- Total Window 3.5–6 hours
- Residual / Half-Life PsychonautWiki's summary sheet does not list a separate after-effect interval. Residual stimulation commonly fades across the offset, but a strong amount still disrupts sleep. Human half-life is not established.
Threshold 2 mg, light 5–15 mg, common 15–25 mg, strong 25–45 mg, heavy above 45 mg. The strong band is wide compared with 4F-MPH, where heavy already begins at 20 mg. That difference is why the two powders cannot share a scoop. Total duration is shorter than 4F-MPH (about 3.5–6 hours).
Quantitatives Wirkungsspektrum (Literaturdaten)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
2 mg
A faint increase in alertness.
Minimal pulse change.
5–15 mg
Gentle focus and wakefulness without much elevated dopaminergic tone.
Mild appetite loss and dry mouth.
15–25 mg
Clear functional stimulation and sociable energy with less edge than the same person's 4F-MPH experience.
Increased heart rate, appetite suppression, and light bruxism.
25–45 mg
Forced wakefulness, anxiety, and scattered attention. The wide strong band is not a license to sit at the top of it.
Tachycardia, vasoconstriction, sweating, and a sharper crash.
45 mg+
Agitation and compulsive repeated exposure. This is still far below a casual 'extra' if someone is thinking in 4-FA milligrams, and far above a 4F-MPH dose.
Hypertensive strain, tremor, severe insomnia, and seizure risk with tramadol or an MAOI.
Wechselwirkungsmatrix — Niemals kombinieren
Lebensgefahr — Niemals kombinieren
Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.
Adds extreme vasoconstriction and seizure risk on top of an already raised heart rate and blood pressure.
Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.
Hohes Risiko — Vermeiden
Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.
The stimulant hides sedation. When it drops, the depressant remains.
Vorsicht / Abschwächung
Additive NDRI effect. 10 mg of 4F-MPH is already a common dose of that drug and is not a small add-on.
Can turn a mild functional stimulant into an anxious one on the offset.
Isomeren- & Strukturvergleich
IPPH is the smoother isopropyl phenidate: common 15–25 mg oral, about 3.5–6 hours, heavy above 45 mg. 4F-MPH is fluorinated methylphenidate, common only 10–15 mg, heavy above 20 mg, with a much longer residual tail. Methylphenidate is the methyl ester and is not dosed from this chart. Neither is 2-FMA, which is a releaser rather than an uptake inhibitor and lasts 7–9 hours.
Stabilität & Lagerung
Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.
Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.
Cross-Tolerance & Dependence Profile
NDRI tolerance and cross-tolerance with methylphenidate, 4F-MPH, and amphetamines. PsychonautWiki's class note is a half-reduction in about 3–7 days and a baseline approach in 1–2 weeks. Psychological dependence shows up as needing the afternoon dose to feel normal. The crash is fatigue and low motivation, not a seizure withdrawal. The wide strong band (25–45 mg) is where repeated daily use quietly settles.
Chemische Struktur und Molekülprofil
IPPH (Isopropylphenidate) (propan-2-yl 2-phenyl-2-piperidin-2-ylacetate) ist eine Referenzverbindung aus der Stoffklasse Phenethylamin-Derivate mit der Summenformel C16H23NO2 und einer molaren Masse von 261.36 g/mol. Die Stammverbindung wird unter der CAS-Nummer 93148-46-0 sowie in der NCBI-PubChem-Datenbank unter CID 68314762 geführt (Standard-InChIKey: AZVPADMEIMLODT-UHFFFAOYSA-N).
Quellen
- PubChem — PubChem (2026-11-12)
Referenztoxikologie und Sicherheitsprofil
Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört IPPH (Isopropylphenidate) zur chemischen Klasse Substituted phenidates. Toxikologische Hinweise (PsychonautWiki): die genaue toxische Schwelle ist in der Fachliteratur nicht festgelegt. Abhängigkeitspotenzial (PsychonautWiki): mäßiges Abhängigkeitspotenzial bei wiederholter Exposition. Dokumentierte Kreuztoleranz: dopamine, stimulant. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.
Quellen
- PubChem — PubChem (2026-11-12)
Analytischer Verwendungszweck und Laborhinweis
Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.
Quellen
- Gesetze im Internet — Neue-psychoaktive-Stoffe-Gesetz (NpSG) & BtMG — Bundesministerium der Justiz (2026-11-12)